EIGHT-YEAR ENTECAVIR THERAPY CONTINUOUSLY REDUCES LIVER ADVERSE EVENTS IN CHRONIC HEPATITIS B PATIENTS WITH CIRRHOSIS

Please use this identifier to cite or link to this item: https://ir.csmu.edu.tw:8080/ir/handle/310902500/24257

Title:	EIGHT-YEAR ENTECAVIR THERAPY CONTINUOUSLY REDUCES LIVER ADVERSE EVENTS IN CHRONIC HEPATITIS B PATIENTS WITH CIRRHOSIS
Authors:	Su, TH;Hu, TH;Chuang, WL;Su, WW;Lin, CC;Peng, CY;Wang, CC;Hsu, YC;Huang, YW;Tseng, KC;Lin, CL;Yang, SS;Suk, FM;Hsu, SJ;Chen, TM;Bair, MJ;Lin, CK;Hsieh, TY;Wang, HY;Tseng, TC;Kao, JH
Date:	2021
Issue Date:	2022-08-05T10:45:37Z (UTC)
Publisher:	WILEY
ISSN:	0270-9139
URI:	https://www.webofscience.com/wos/woscc/full-record/WOS:000707188002196 https://ir.csmu.edu.tw:8080/handle/310902500/24257
Relation:	HEPATOLOGY ,2021 ,v74 ,p482A-482A
Appears in Collections:	[中山醫學大學研究成果] 其他文獻

Files in This Item:

There are no files associated with this item.